OpenURL Connection Search

Select item for more details and to access through your institution.

Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.
Published in:
Journal of Clinical Apheresis, 2023, v. 38, n. 1, p. 33, doi. 10.1002/jca.22022
By:
- Partanen, Anu;
- Turunen, Antti;
- Silvennoinen, Raija;
- Valtola, Jaakko;
- Pyörälä, Marja;
- Siitonen, Timo;
- Sikiö, Anu;
- Putkonen, Mervi;
- Sankelo, Marja;
- Penttilä, Karri;
- Kuittinen, Taru;
- Mäntymaa, Pentti;
- Pelkonen, Jukka;
- Jantunen, Esa;
- Varmavuo, Ville
Publication type:
Article
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.
Published in:
2019
By:
- Luoma, Sini;
- Anttila, Pekka;
- Säily, Marjaana;
- Lundan, Tuija;
- Heiskanen, Jouni;
- Siitonen, Timo;
- Kakko, Sakari;
- Putkonen, Mervi;
- Ollikainen, Hanna;
- Terävä, Venla;
- Sankelo, Marja;
- Partanen, Anu;
- Launonen, Kirsi;
- Räsänen, Anu;
- Sikiö, Anu;
- Suominen, Merja;
- Bazia, Piotr;
- Kananen, Kristiina;
- Lievonen, Juha;
- Selander, Tuomas
Publication type:
journal article
Cost analysis of a randomized stem cell mobilization study in multiple myeloma.
Published in:
2016
By:
- Varmavuo, Ville;
- Silvennoinen, Raija;
- Anttila, Pekka;
- Säily, Marjaana;
- Sankelo, Marja;
- Putkonen, Mervi;
- Ahonen, Jouni;
- Mahlamäki, Eija;
- Mäntymaa, Pentti;
- Savolainen, Eeva-Riitta;
- Remes, Kari;
- Jantunen, Esa
Publication type:
journal article
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.
Published in:
Cancers, 2024, v. 16, n. 5, p. 1024, doi. 10.3390/cancers16051024
By:
- Partanen, Anu;
- Waage, Anders;
- Peceliunas, Valdas;
- Schjesvold, Fredrik;
- Anttila, Pekka;
- Säily, Marjaana;
- Uttervall, Katarina;
- Putkonen, Mervi;
- Carlson, Kristina;
- Haukas, Einar;
- Sankelo, Marja;
- Szatkowski, Damian;
- Hansson, Markus;
- Marttila, Anu;
- Svensson, Ronald;
- Axelsson, Per;
- Lauri, Birgitta;
- Mikkola, Maija;
- Karlsson, Conny;
- Abelsson, Johanna
Publication type:
Article
Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy.
Published in:
Cancers, 2023, v. 15, n. 9, p. 2604, doi. 10.3390/cancers15092604
By:
- Luoma, Sini;
- Sergeev, Philipp;
- Javarappa, Komal Kumar;
- Öhman, Tiina J.;
- Varjosalo, Markku;
- Säily, Marjaana;
- Anttila, Pekka;
- Sankelo, Marja;
- Partanen, Anu;
- Nihtinen, Anne;
- Heckman, Caroline A.;
- Silvennoinen, Raija
Publication type:
Article
Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group
Published in:
European Journal of Haematology, 2022, v. 109, n. 3, p. 257, doi. 10.1111/ejh.13805
By:
- Kolonen, Aarne;
- Sinisalo, Marjatta;
- Huhtala, Heini;
- Rimpiläinen, Johanna;
- Rintala, Hannele;
- Sankelo, Marja;
- Koivunen, Elli;
- Silvennoinen, Raija;
- Räty, Riikka;
- Ruutu, Tapani;
- Volin, Liisa;
- Porkka, Kimmo;
- Jantunen, Esa;
- Nousiainen, Tapio;
- Kuittinen, Taru;
- Penttilä, Karri;
- Pyörälä, Marja;
- Säily, Marjaana;
- Koistinen, Pirjo;
- Kauppila, Marjut
Publication type:
Article
P-067: High dimensional CyTOF analysis of the immune system of multiple myeloma patients with different responses to lenalidomide maintenance.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S75, doi. 10.1016/S2152-2650(21)02201-1
By:
- Silvennoinen, Raija;
- Javarappa, Komal Kumar;
- Luoma, Sini;
- Sergeev, Philipp;
- Anttila, Pekka;
- Öhman, Tiina;
- Varjosalo, Markku;
- Säily, Marjaana;
- Partanen, Anu;
- sankelo, Marja;
- Heckman, Caroline
Publication type:
Article
A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e279, doi. 10.1016/j.clml.2019.09.460
By:
- Silvennoinen, Raija;
- Majumder, Muntasir Mamun;
- Tsallos, Dimitrios;
- Nahi, Hareth;
- Anttila, Pekka;
- Partanen, Anu;
- Luoma, Sini;
- Sikiö, Anu;
- Nurmi, Marita;
- Varmavuo, Ville;
- Säily, Marjaana;
- Sankelo, Marja;
- Jantunen, Esa;
- Pelliniemi, Tarja-Terttu;
- Ilveskero, Sorella;
- Eshoj, Henrik Rode;
- Nielsen, Lene Kongsgaard;
- Eldfors, Samuli;
- Leppä, Aino-Maija;
- Heckman, Caroline
Publication type:
Article
Accurate genetic diagnosis of Finnish pulmonary arterial hypertension patients using oligonucleotide-selective sequencing.
Published in:
Molecular Genetics & Genomic Medicine, 2015, v. 3, n. 4, p. 354, doi. 10.1002/mgg3.147
By:
- Vattulainen, Sanna;
- Aho, Joonas;
- Salmenperä, Pertteli;
- Bruce, Siina;
- Tallila, Jonna;
- Gentile, Massimiliano;
- Sankelo, Marja;
- Laitinen, Tarja;
- Koskenvuo, Juha W.;
- Alastalo, Tero‐Pekka;
- Myllykangas, Samuel
Publication type:
Article
Comparison of CD34+ cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study.
Published in:
Transfusion, 2021, v. 61, n. 11, p. 3202, doi. 10.1111/trf.16645
By:
- Anu, Partanen;
- Antti, Turunen;
- Raija, Silvennoinen;
- Marja, Pyörälä;
- Jaakko, Valtola;
- Timo, Siitonen;
- Mervi, Putkonen;
- Marja, Sankelo;
- Anu, Sikiö;
- Karri, Penttilä;
- Taru, Kuittinen;
- Jukka, Pelkonen;
- Pentti, Mäntymaa;
- Esa, Jantunen;
- Ville, Varmavuo
Publication type:
Article
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.
Published in:
Transfusion, 2021, v. 61, n. 6, p. 1830, doi. 10.1111/trf.16424
By:
- Turunen, Antti;
- Silvennoinen, Raija;
- Partanen, Anu;
- Valtola, Jaakko;
- Siitonen, Timo;
- Putkonen, Mervi;
- Sankelo, Marja;
- Pyörälä, Marja;
- Kuittinen, Taru;
- Penttilä, Karri;
- Sikiö, Anu;
- Savolainen, Eeva‐Riitta;
- Mäntymaa, Pentti;
- Pelkonen, Jukka;
- Varmavuo, Ville;
- Jantunen, Esa
Publication type:
Article
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.
Published in:
2020
By:
- Turunen, Antti;
- Partanen, Anu;
- Valtola, Jaakko;
- Ropponen, Antti;
- Siitonen, Timo;
- Kuittinen, Outi;
- Kuitunen, Hanne;
- Putkonen, Mervi;
- Sankelo, Marja;
- Keskinen, Leena;
- Savolainen, Eeva‐Riitta;
- Pyörälä, Marja;
- Kuittinen, Taru;
- Silvennoinen, Raija;
- Penttilä, Karri;
- Sikiö, Anu;
- Vasala, Kaija;
- Mäntymaa, Pentti;
- Pelkonen, Jukka;
- Varmavuo, Ville
Publication type:
journal article
Impact of lenalidomide-based induction therapy on the mobilization of CD34+ cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.
Published in:
2017
By:
- Partanen, Anu;
- Valtola, Jaakko;
- Silvennoinen, Raija;
- Ropponen, Antti;
- Siitonen, Timo;
- Putkonen, Mervi;
- Sankelo, Marja;
- Pelkonen, Jukka;
- Mäntymaa, Pentti;
- Varmavuo, Ville;
- Jantunen, Esa;
- Mäntymaa, Pentti
Publication type:
journal article
Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.
Published in:
2016
By:
- Valtola, Jaakko;
- Silvennoinen, Raija;
- Ropponen, Antti;
- Siitonen, Timo;
- Säily, Marjaana;
- Sankelo, Marja;
- Terävä, Venla;
- Putkonen, Mervi;
- Kuittinen, Taru;
- Pelkonen, Jukka;
- Mäntymaa, Pentti;
- Remes, Kari;
- Varmavuo, Ville;
- Jantunen, Esa
Publication type:
journal article
BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.
Published in:
Human Mutation, 2005, v. 26, n. 2, p. 119, doi. 10.1002/humu.20200
By:
- Sankelo, Marja;
- Flanagan, Julia A;
- Machado, Rajiv;
- Harrison, Rachel;
- Rudarakanchana, Nung;
- Morrell, Nicholas;
- Dixon, Morag;
- Halme, Maija;
- Puolijoki, Hannu;
- Kere, Juha;
- Elomaa, Outi;
- Kupari, Markku;
- Räisänen-Sokolowski, Anne;
- Trembath, Richard C.;
- Laitinen, Tarja
Publication type:
Article

Found: 15

Impact of the number of cryopreserved CD34<sup>+</sup> cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study.

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy.

Efficacy of conventional‐dose cytarabine, idarubicin and thioguanine versus intermediate‐dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long‐term results of the prospective randomized nationwide AML‐2003 study by the Finnish Leukemia Group

P-067: High dimensional CyTOF analysis of the immune system of multiple myeloma patients with different responses to lenalidomide maintenance.

A phase 2 study of carfilzomib plus elotuzumab plus dexamethasone for myeloma patients relapsed after 1-3 prior treatment lines.

Accurate genetic diagnosis of Finnish pulmonary arterial hypertension patients using oligonucleotide-selective sequencing.

Comparison of CD34<sup>+</sup> cell mobilization, blood graft cellular composition, and post‐transplant outcome in myeloma patients mobilized with filgrastim or pegfilgrastim added to low‐dose cyclophosphamide: A prospective multicenter study.

Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.

CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.

Impact of lenalidomide-based induction therapy on the mobilization of CD34<sup>+</sup> cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study.

Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.

BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.